000 | 01851 a2200493 4500 | ||
---|---|---|---|
005 | 20250516115307.0 | ||
264 | 0 | _c20130405 | |
008 | 201304s 0 0 eng d | ||
022 | _a1600-0625 | ||
024 | 7 |
_a10.1111/exd.12002 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aReichenbach, Gabi | |
245 | 0 | 0 |
_aLigand activation of peroxisome proliferator-activated receptor delta suppresses cathepsin B expression in human endothelial cells in a posttranslational manner. _h[electronic resource] |
260 |
_bExperimental dermatology _cOct 2012 |
||
300 |
_a751-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 | _a3' Untranslated Regions |
650 | 0 | 4 | _aBase Sequence |
650 | 0 | 4 |
_aCathepsin B _xantagonists & inhibitors |
650 | 0 | 4 |
_aDEAD-box RNA Helicases _xantagonists & inhibitors |
650 | 0 | 4 |
_aEndothelial Cells _xdrug effects |
650 | 0 | 4 |
_aGene Expression _xdrug effects |
650 | 0 | 4 | _aGene Knockdown Techniques |
650 | 0 | 4 | _aHuman Umbilical Vein Endothelial Cells |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aLigands |
650 | 0 | 4 |
_aMicroRNAs _xgenetics |
650 | 0 | 4 |
_aPPAR delta _xagonists |
650 | 0 | 4 |
_aPhenoxyacetates _xpharmacology |
650 | 0 | 4 |
_aProtein Processing, Post-Translational _xdrug effects |
650 | 0 | 4 |
_aRNA, Small Interfering _xgenetics |
650 | 0 | 4 |
_aRibonuclease III _xantagonists & inhibitors |
650 | 0 | 4 |
_aThiazoles _xpharmacology |
700 | 1 | _aStarzinski-Powitz, Anna | |
700 | 1 | _aDoll, Monika | |
700 | 1 | _aHrgovic, Igor | |
700 | 1 | _aValesky, Eva Maria | |
700 | 1 | _aKippenberger, Stefan | |
700 | 1 | _aBernd, August | |
700 | 1 | _aKaufmann, Roland | |
700 | 1 | _aMeissner, Markus | |
773 | 0 |
_tExperimental dermatology _gvol. 21 _gno. 10 _gp. 751-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1111/exd.12002 _zAvailable from publisher's website |
999 |
_c22195019 _d22195019 |